Elevated retinol binding protein 4 levels are associated with atherosclerosis in diabetic rats via JAK2/STAT3 signaling pathway

doi:10.4239/wjd.v12.i4.466

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6231)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-5) series.

Item

Count

PDF

273

WORD

186

HTML

2745

Figures (1-6)

201

Tables (1-5)

202

Sum=3607

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

318

Download

697

Sum=1015

Publishing Process of This Article

Item

Count

Browse

539

Download

1070

Sum=1609

Apr 15, 2021 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Apr 15, 2021; 12(4): 466-479
Published online Apr 15, 2021. doi: 10.4239/wjd.v12.i4.466

Full Size Figure Download Figure

Figure 3 Comparisons of protein expression of retinol binding protein 4 in each group. ^aP < 0.05 vs control group, ^bP < 0.05 vs diabetic rat group. RBP4: Retinol binding protein 4; NC: Control group; DM: Diabetic rat group; DA: Diabetic atherosclerotic rat group.

Citation: Zhou W, Ye SD, Wang W. Elevated retinol binding protein 4 levels are associated with atherosclerosis in diabetic rats via JAK2/STAT3 signaling pathway. World J Diabetes 2021; 12(4): 466-479
URL: https://www.wjgnet.com/1948-9358/full/v12/i4/466.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i4.466